Comparison of different treatments for HPV+ oropharyngeal carcinoma: a network meta-analysis.

Fausto PetrelliMassimiliano NardoneFrancesca TrevisanDaniela CarioliVincenzo FalascaAgostina De StefaniVincenzo CapriottiCristina GurizzanLuigi LoriniAlfredo BerrutiAndrea LucianiPaolo Bossi

Published in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2022)

This meta-analysis confirms the role of cisplatin added to RT as the best option for HPV+ oropharyngeal carcinoma. RT+ 3-weekly cisplatin is likely to be the best radical treatment in terms of OS and PFS.

Keyphrases

systematic review
high grade
meta analyses
cervical cancer screening
combination therapy